4.6 Article

Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference

Related references

Note: Only part of the references are listed.
Review Cardiac & Cardiovascular Systems

Patient-reported outcome measures in cardiovascular disease

Ran Kornowski

Summary: In today's medical ecosystem, measuring the outcomes most important to patients is crucial. Patient-reported outcome measures (PROMS) can serve as essential metrics for delivering high-quality cardiovascular care, but a lack of standardization makes it challenging to compare outcomes across treatments. By leveraging information technology, sophisticated data analysis using patient-derived data and randomization can generate impactful metrics to inform decision-making.

EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES (2023)

Article Clinical Neurology

Examining racial disparities in the diagnosis of mild cognitive impairment

Andrew M. Kiselica et al.

Summary: Black individuals are more likely to be overdiagnosed with mild cognitive impairment (MCI) while White individuals are more likely to be underdiagnosed. The use of neuropsychological test data and actuarial approaches may help reduce racial disparities in the diagnosis of MCI, but issues related to race-based norming and differential symptom presentations complicate interpretation of the results.

APPLIED NEUROPSYCHOLOGY-ADULT (2023)

Article Cardiac & Cardiovascular Systems

MRI-Detected Brain Lesions and Cognitive Function in Patients With Atrial Fibrillation Undergoing Left Atrial Catheter Ablation in the Randomized AXAFA-AFNET 5 Trial

Karl Georg Hausler et al.

Summary: This study aimed to evaluate the impact of apixaban on brain damage in patients with atrial fibrillation (AF) after ablation. The study found a high incidence of acute brain lesions in patients treated with apixaban or vitamin K antagonist after ablation, but they were not associated with cognitive function. However, chronic white matter damage was associated with cognitive function before and after ablation, especially with age. This suggests that uninterrupted oral anticoagulation during AF ablation is safe.

CIRCULATION (2022)

Article Cardiac & Cardiovascular Systems

Atrial Fibrillation and Dementia: A Report From the AF-SCREEN International Collaboration

Lena Rivard et al.

Summary: Growing evidence suggests an association between atrial fibrillation (AF) and cognitive impairment and dementia, independent of stroke. The report provides guidance on investigating and managing dementia in AF patients based on the best available evidence. Further research is needed to determine the direct causal effect and explore potential pathophysiological mechanisms.

CIRCULATION (2022)

Article Cardiac & Cardiovascular Systems

Molecular imaging of atrial myopathy: Towards early AF detection and non-invasive disease management

Martin Ezeani et al.

Summary: Atrial fibrillation is a common arrhythmia that can lead to stroke, with current diagnostic methods focusing on functional and morphological abnormalities of the left atria. However, there is a lack of robust screening methods for early detection of atrial muscle disease.

TRENDS IN CARDIOVASCULAR MEDICINE (2022)

Article Cardiac & Cardiovascular Systems

Interactions Between Atrial Fibrillation and Natriuretic Peptide in Predicting Heart Failure Hospitalization or Cardiovascular Death

Paul F. Brady et al.

Summary: This study found that elevated NT-proBNP concentrations predict future heart failure events in patients with atrial fibrillation, regardless of the presence of heart failure.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)

Article Cardiac & Cardiovascular Systems

Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST-AFNET 4 trial

Andreas Metzner et al.

Summary: Treatment patterns were compared between randomized groups in EAST-AFNET 4 to assess potential explanations for the clinical benefit achieved with early rhythm control. The study found that the type of rhythm control varied by country and center, with more antiarrhythmic drugs and AF ablation used in the early therapy group. However, there was no significant difference in the treatment of concomitant conditions between groups.

EUROPACE (2022)

Article Cardiac & Cardiovascular Systems

Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial

Stephan Willems et al.

Summary: The EAST-AFNET 4 trial showed that early, systematic rhythm control therapy improves clinical outcomes in both symptomatic and asymptomatic atrial fibrillation patients.

EUROPEAN HEART JOURNAL (2022)

Editorial Material Cardiac & Cardiovascular Systems

The importance of adherence and persistence with oral anticoagulation treatment in patients with atrial fibrillation

Marco Vitolo et al.

Summary: This editorial discusses the associations between long-term persistence and adherence with non-vitamin K oral anticoagulants in patients with atrial fibrillation and stroke risk.

EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2021)

Article Cardiac & Cardiovascular Systems

Atrial Fibrillation in Indigenous Australians: A Multisite Screening Study Using a Single-Lead ECG Device in Aboriginal Primary Health Settings

Josephine Gwynn et al.

Summary: This study is the first national community prevalence and age distribution of atrial fibrillation (AF) in Australian Aboriginal people. The results showed a 4.7% AF diagnosis rate in this population, increasing with age. Screening for AF in Aboriginal people is recommended to start at the age of 55.

HEART LUNG AND CIRCULATION (2021)

Article Cardiac & Cardiovascular Systems

Cognitive impairment in patients with atrial fibrillation: Implications for outcome in a cohort study

Vincenzo Livio Malavasi et al.

Summary: Cognitive impairment in patients with atrial fibrillation is associated with worse outcomes, particularly in patients previously treated with antiplatelet drugs without oral anticoagulation. This study highlights the potential role of appropriate antithrombotic treatment for improving patient prognosis in cardiovascular patients.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Association of anticoagulant therapy with risk of dementia among patients with atrial fibrillation

Daehoon Kim et al.

Summary: The study found that among patients with atrial fibrillation, non-vitamin K antagonist oral anticoagulants (NOACs) were associated with a lower risk of dementia.

EUROPACE (2021)

Article Cardiac & Cardiovascular Systems

Quality indicators for the care and outcomes of adults with atrial fibrillation

Elena Arbelo et al.

Summary: This paper aimed to develop quality indicators (QIs) for evaluating the quality of care and outcomes for adults with atrial fibrillation (AF). Six domains of care were identified, and a total of 17 main and 17 secondary QIs were selected to cover these domains, with the expectation that implementing these QIs will improve the quality of AF care.

EUROPACE (2021)

Article Cardiac & Cardiovascular Systems

Screen-detected atrial fibrillation predicts mortality in elderly subjects

Matthias D. Zink et al.

Summary: Pharmacy-based, automated AF screening in elderly citizens identified subjects with unknown AF and an excess mortality risk over the next year. Participants with newly diagnosed or known AF had a significantly higher mortality risk compared with subjects without a history of AF at baseline and a normal ECG.

EUROPACE (2021)

Article Cardiac & Cardiovascular Systems

Accuracy of left atrial fibrosis detection with cardiac magnetic resonance: correlation of late gadolinium enhancement with endocardial voltage and conduction velocity

Gala Caixal et al.

Summary: The study analyzed the accuracy of LGE-MRI in identifying the arrhythmogenic substrate in the left atrium, showing that areas with higher LGE exhibit lower voltage and slower conduction. Furthermore, in patients with dilated atria (LA diameter >= 45), the predictive capacity of LGE-MRI for conduction velocity may be weaker.

EUROPACE (2021)

Article Cardiac & Cardiovascular Systems

Prediction of low-voltage areas using modified APPLE score

Timm Seewoester et al.

Summary: The study compared the modified (m)APPLE score, including LA volume and LA emptying fraction, with the regular APPLE score for the prediction of LVAs in patients undergoing first AF catheter ablation. The modified (m)APPLE score demonstrated good prognostic value for LVAs prediction, showing better performance than the regular APPLE score, although without statistically significant difference.

EUROPACE (2021)

Article Cardiac & Cardiovascular Systems

Explainable artificial intelligence to detect atrial fibrillation using electrocardiogram

Yong-Yeon Jo et al.

Summary: A explainable deep learning model was developed and validated for detecting atrial fibrillation using diverse formats of electrocardiograms. The model achieved high performance in both internal and external validation, suggesting its potential application in clinical practice.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Long-term intermittent versus short continuous heart rhythm monitoring for the detection of atrial fibrillation recurrences after catheter ablation

Astrid N. L. Hermans et al.

Summary: This study compared the efficacy and usability of long-term intermittent vs short continuous heart rhythm monitoring for the detection of AF recurrences after AF ablation, finding that long-term intermittent monitoring by ACK was more effective and had higher patient usability. ACK showed high accuracy in detecting AF.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2021)

Article Medicine, General & Internal

Cryoballoon Ablation as Initial Therapy for Atrial Fibrillation

Oussama M. Wazni et al.

Summary: In this multicenter trial, cryoballoon ablation as initial therapy was found to be superior to drug therapy in preventing atrial arrhythmia recurrence in patients with paroxysmal atrial fibrillation. Serious procedure-related adverse events were uncommon.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation

Jason G. Andrade et al.

Summary: In patients with symptomatic, paroxysmal atrial fibrillation, catheter cryoballoon ablation was associated with a significantly lower rate of atrial fibrillation recurrence compared to antiarrhythmic drug therapy. The ablation group also had better outcomes in terms of atrial tachyarrhythmia occurrence and atrial fibrillation burden.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Cardiac & Cardiovascular Systems

Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure Results From the CABANA Trial

Douglas L. Packer et al.

Summary: The CABANA trial showed that catheter ablation in patients with heart failure and atrial fibrillation can significantly improve survival, reduce AF recurrence, and enhance quality of life compared to drug therapy.

CIRCULATION (2021)

Editorial Material Cardiac & Cardiovascular Systems

Digital, risk-based screening for atrial fibrillation in the European community-the AFFECT-EU project funded by the European Union

Daniel Engler et al.

EUROPEAN HEART JOURNAL (2021)

Article Cardiac & Cardiovascular Systems

Efficacy of LGE-MRI-guided fibrosis ablation versus conventional catheter ablation of atrial fibrillation: The DECAAF II trial: Study design

Nassir F. Marrouche et al.

Summary: The DECAAF II trial is a prospective, randomized, multicenter trial assessing the safety and efficacy of targeting atrial fibrosis during ablation of persistent AF patients. With 900 patients enrolled, the study aims to define the optimal approach to catheter ablation of persistent AF and identify influencers of ablation lesion formation.

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2021)

Article Medicine, General & Internal

Quantification of fibroblast growth factor 23 and N-terminal pro-B-type natriuretic peptide to identify patients with atrial fibrillation using a high-throughput platform: A validation study

Winnie Chua et al.

Summary: This study validated the reliability of an AF model using standardized, high-throughput, high-sensitivity biomarker assays. The results indicate that elevated NT-proBNP and FGF23, combined with age, sex, and BMI, can accurately identify patients with AF.

PLOS MEDICINE (2021)

Review Cardiac & Cardiovascular Systems

How machine learning is impacting research in atrial fibrillation: implications for risk prediction and future management

Ivan Olier et al.

Summary: The exponential growth of artificial intelligence and machine learning publications in the field of atrial fibrillation mainly focuses on utilizing deep neural networks and open access databases for ML applications, with particular attention on using ECGs for AF detection. AI/ML can expand the utility of AF detection and risk prediction, leading to improvement in clinical care for patients with AF.

CARDIOVASCULAR RESEARCH (2021)

Article Cardiac & Cardiovascular Systems

Echocardiographic diagnosis of atrial cardiomyopathy allows outcome prediction following pulmonary vein isolation

Martin Eichenlaub et al.

Summary: The study aimed to assess two non-invasive echocardiographic parameters, LA emptying fraction (EF) and LA longitudinal strain (LAS), for the diagnosis of ACM and prediction of arrhythmia outcome after PVI.

CLINICAL RESEARCH IN CARDIOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Proximity to the descending aorta predicts regional fibrosis in the adjacent left atrial wall: aetiopathogenic and prognostic implications

Gala Caixal et al.

Summary: This study found that atrial fibrosis is mainly located in the area adjacent to the descending aorta and increases with the proximity between the two structures. Regional fibrosis near the descending aorta better predicted recurrence after AF ablation.

EUROPACE (2021)

Article Cardiac & Cardiovascular Systems

The European TeleCheck-AF project on remote app-based management of atrial fibrillation during the COVID-19 pandemic: centre and patient experiences

Monika Gawalko et al.

Summary: The TeleCheck-AF project aimed to maintain care delivery for AF patients during COVID-19 through teleconsultations and heart rate monitoring. Most participating centres were academic with AF outpatient clinics. The inclusion rate was highest during lockdown and decreased after easing restrictions.

EUROPACE (2021)

Article Cardiac & Cardiovascular Systems

Temporal Association Between Episodes of Atrial Fibrillation and Risk of Ischemic Stroke

Daniel E. Singer et al.

Summary: This study aimed to define the temporal association between episodes of atrial fibrillation (AF) and stroke in patients with cardiac implantable electronic devices (CIEDs). The results showed that the risk of stroke was highest within 5 days of an episode of AF lasting 5.5 hours or more. The findings support trials of time-limited anticoagulation for patients with infrequent multi-hour episodes of AF and rigorous, continuous rhythm monitoring.

JAMA CARDIOLOGY (2021)

Article Medicine, General & Internal

Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke

Richard P. Whitlock et al.

Summary: Surgical occlusion of the left atrial appendage has been shown to reduce the risk of ischemic stroke or systemic embolism in patients with atrial fibrillation undergoing cardiac surgery, with no significant difference in perioperative complications between the occlusion and non-occlusion groups.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

Treatment timing and the effects of rhythm control strategy in patients with atrial fibrillation: nationwide cohort study

Daehoon Kim et al.

Summary: This study investigated the outcomes of rhythm control versus rate control strategies in 22,635 adults with atrial fibrillation in Korea. The results showed that early initiation of rhythm control treatment was associated with a lower risk of adverse cardiovascular outcomes compared to rate control treatment, while no difference was found in patients with late treatment initiation.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Article Cardiac & Cardiovascular Systems

Screening for Atrial Fibrillation in American Indian Adults in a Tribal Primary Care Clinic

Stavros Stavrakis et al.

Summary: Opportunistic screening for atrial fibrillation using a mobile, single-lead ECG device in tribal health clinics can detect more cases of AF compared to usual care, leading to appropriate initiation of anticoagulation. AF develops at a younger age in American Indian adults who may benefit from earlier screening.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)

Article Medicine, General & Internal

Non-Invasive and Quantitative Estimation of Left Atrial Fibrosis Based on P Waves of the 12-Lead ECG-A Large-Scale Computational Study Covering Anatomical Variability

Claudia Nagel et al.

Summary: The arrhythmogenesis of atrial fibrillation is linked to fibrotic atrial tissue, with altered morphology of the P wave in the 12-lead ECG reflecting physiological anatomical variability of the atria and thorax. By simulating various anatomical properties, a neural network was able to estimate the volume fraction of atrial fibrosis with high accuracy, suggesting potential for non-invasive detection of atrial fibrotic cardiomyopathy.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Cardiac & Cardiovascular Systems

Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure

Andreas Rillig et al.

Summary: The study demonstrates that early rhythm control therapy is beneficial in reducing cardiovascular events in patients with heart failure and atrial fibrillation. Additionally, the therapy helps to improve left ventricular ejection fraction in heart failure patients.

CIRCULATION (2021)

Article Cardiac & Cardiovascular Systems

Non-invasive body surface electrocardiographic imaging for diagnosis of atrial cardiomyopathy

Martin Eichenlaub et al.

Summary: The study confirmed the feasibility of diagnosing ACM using non-invasive ECGI, and found that the total atrial conduction time in ECGI is closely related to the risk of arrhythmia recurrence in patients with ACM.

EUROPACE (2021)

Article Cardiac & Cardiovascular Systems

Prognostic markers of all-cause mortality in patients with atrial fibrillation: data from the prospective long-term registry of the German Atrial Fibrillation NETwork (AFNET)

Michael Nabauer et al.

Summary: The study found that mortality in atrial fibrillation patients primarily stems from heart failure, peripheral artery disease, chronic obstructive lung disease, chronic kidney disease, and diabetes mellitus, which should be targeted in efforts to lower mortality. Additionally, sex-specific age was identified as the strongest predictor of mortality.

EUROPACE (2021)

Article Cardiac & Cardiovascular Systems

AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial

Michele Brignole et al.

Summary: Ablation + CRT treatment is superior in reducing all-cause mortality in severely symptomatic permanent AF patients. Furthermore, this treatment also significantly lowers the combined endpoint of all-cause mortality or HF hospitalization.

EUROPEAN HEART JOURNAL (2021)

Article Medicine, General & Internal

Implantable loop recorder detection of atrial fibrillation to prevent stroke ( The LOOP Study): a randomised controlled trial

Jesper H. Svendsen et al.

Summary: In individuals with stroke risk factors, ILR screening resulted in a three-times increase in atrial fibrillation detection and anticoagulation initiation but no significant reduction in the risk of stroke or systemic arterial embolism. These findings might imply that not all atrial fibrillation is worth screening for, and not all screen-detected atrial fibrillation merits anticoagulation.

LANCET (2021)

Article Medicine, General & Internal

Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial

Emma Svennberg et al.

Summary: A randomized controlled trial in Sweden showed that systematic screening for atrial fibrillation in older populations can reduce mortality and morbidity compared to no screening.

LANCET (2021)

Article Medicine, General & Internal

Redefining β-blocker response in heart failure patients with sinus rhythm and atrial fibrillation: a machine learning cluster analysis

Andreas Karwath et al.

Summary: This study utilized artificial intelligence to investigate the efficacy of beta-blockers in patients with heart failure, finding varying responses to the drug based on different heart rhythms.

LANCET (2021)

Article Clinical Neurology

Systematic monitoring for detection of atrial fibrillation in patients with acute ischaemic stroke (MonDAFIS): a randomised, open-label, multicentre study

Karl Georg Haeusler et al.

Summary: Systematic ECG monitoring can increase the detection rate of atrial fibrillation in patients hospitalized with acute ischemic stroke or transient ischemic attack, but it does not significantly affect the rate of oral anticoagulant use after 12 months. Further efforts are needed to improve secondary stroke prevention.

LANCET NEUROLOGY (2021)

Article Clinical Neurology

Comparing Warfarin and 4 Direct Oral Anticoagulants for the Risk of Dementia in Patients With Atrial Fibrillation

So-Ryoung Lee et al.

Summary: The study found that among patients with atrial fibrillation, there was no significant difference in the risk of dementia between those treated with DOACs and warfarin. However, DOACs may be more beneficial than warfarin in younger patients or those with a history of stroke. Among the different DOACs, only edoxaban was associated with a lower risk of dementia compared to warfarin.

STROKE (2021)

Article Cardiac & Cardiovascular Systems

Patient-Reported Outcomes and Patient-Reported Experience of Patients With Atrial Fibrillation in the IMPACT-AF Clinical Trial

Brittany Humphries et al.

Summary: The IMPACT-AF trial compared atrial fibrillation management with a computerized clinical decision support system to usual care in Nova Scotia, Canada. The study found that over 12 months, patients' health-related quality of life remained stable, with no significant differences in patient satisfaction or utility scores between the clinical decision support and control groups.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)

Article Medicine, General & Internal

Exercise and the Risk of Dementia in Patients with Newly Diagnosed Atrial Fibrillation: A Nationwide Population-Based Study

Jaehyun Lim et al.

Summary: The change in physical activity before and after new-onset atrial fibrillation is associated with the risk of incident dementia, with exercise starters and maintainers showing a lower risk compared to non-exercisers. There is a J-shaped relationship between exercise dose and dementia risk, with maximum risk reduction seen at 5-6 times per week of moderate-to-vigorous physical activity among exercise starters.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Cardiac & Cardiovascular Systems

Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference

Larissa Fabritz et al.

Summary: This article summarizes the outcomes of the 7th Consensus Conference of the Atrial Fibrillation NETwork (AFNET) and the European Heart Rhythm Association (EHRA), focusing on key issues in AF prevention, management, and future research to improve care for patients with AF and prevent AF-related complications. The discussions among international AF specialists highlighted the importance of understanding dynamic risk profiles in AF patients, utilizing deeply phenotyped datasets for better insights, and proposing new algorithms and strategies for acute management, stroke risk assessment, anticoagulation use, and rhythm control therapy selection. The conclusion emphasizes the need for better characterization of morbidity and mortality in patients with AF, with a focus on addressing AF burden and concomitant conditions for stratified therapy.

EUROPACE (2021)

Article Cardiac & Cardiovascular Systems

Improved brain perfusion after electrical cardioversion of atrial fibrillation

Marianna Gardarsdottir et al.

EUROPACE (2020)

Editorial Material Medicine, General & Internal

Time to develop guidelines for screening and management of atrial fibrillation in Indigenous Australians

Nicole Lowres et al.

MEDICAL JOURNAL OF AUSTRALIA (2020)

Editorial Material Cardiac & Cardiovascular Systems

STEEER-AF: a cluster-randomized education trial fromthe ESC

Karina V. Bunting et al.

EUROPEAN HEART JOURNAL (2020)

Article Peripheral Vascular Disease

Blood Pressure Control and Dementia Risk in Midlife Patients With Atrial Fibrillation

Daehoon Kim et al.

HYPERTENSION (2020)

Article Cardiac & Cardiovascular Systems

Mobile Health Technology to Improve Care for Patients With Atrial Fibrillation

Yutao Guo et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Article Cardiac & Cardiovascular Systems

Emerging Technologies for Identifying Atrial Fibrillation

Eric Y. Ding et al.

CIRCULATION RESEARCH (2020)

Article Cardiac & Cardiovascular Systems

Magnetic Resonance Imaging-Guided Fibrosis Ablation for the Treatment of Atrial Fibrillation The ALICIA Trial

Felipe Bisbal et al.

CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2020)

Article Cardiac & Cardiovascular Systems

Less dementia after catheter ablation for atrial fibrillation: a nationwide cohort study

Daehoon Kim et al.

EUROPEAN HEART JOURNAL (2020)

Article Cardiac & Cardiovascular Systems

Is the abnormal conduction zone of the left atrium a precursor to a low voltage area in patients with atrial fibrillation?

Hideyuki Kishima et al.

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2020)

Article Cardiac & Cardiovascular Systems

Atrial Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation

Yogesh N.V. Reddy et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Article Medicine, General & Internal

Early Rhythm-Control Therapy in Patients with Atrial Fibrillation

Paulus Kirchhof et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Opportunistic screening versus usual care for detection of atrial fibrillation in primary care: cluster randomised controlled trial

Steven B. Uittenbogaart et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Article Cardiac & Cardiovascular Systems

Artificial Intelligence-Electrocardiography to Predict Incident Atrial Fibrillation A Population-Based Study

Georgios Christopoulos et al.

CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2020)

Article Cardiac & Cardiovascular Systems

Less dementia after catheter ablation for atrial fibrillation: a nationwide cohort study

Daehoon Kim et al.

EUROPEAN HEART JOURNAL (2020)

Article Cardiac & Cardiovascular Systems

Atrial fibrillation ablation in practice: assessing CABANA generalizability

Peter A. Noseworthy et al.

EUROPEAN HEART JOURNAL (2019)

Article Medicine, General & Internal

Effect of Catheter Ablation vs Antiarrhythmic Medication on Quality of Life in Patients With Atrial Fibrillation The CAPTAF Randomized Clinical Trial

Carina Blomstrom-Lundqvist et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)

Article Medicine, General & Internal

Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation The CABANA Randomized Clinical Trial

Daniel B. Mark et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)

Article Cardiac & Cardiovascular Systems

Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial

Stefan H. Hohnloser et al.

EUROPEAN HEART JOURNAL (2019)

Article Cardiac & Cardiovascular Systems

Less dementia and stroke in low-risk patients with atrial fibrillation taking oral anticoagulation

Leif Friberg et al.

EUROPEAN HEART JOURNAL (2019)

Article Cell Biology

FGF23 regulates atrial fibrosis in atrial fibrillation by mediating the STAT3 and SMAD3 pathways

Quanbin Dong et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2019)

Article Cardiac & Cardiovascular Systems

Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a population-based cohort

Dongmin Kim et al.

EUROPEAN HEART JOURNAL (2019)

Article Cardiac & Cardiovascular Systems

Correlation of P-wave properties with the size of left atrial low voltage areas in patients with atrial fibrillation

Tobias Schreiber et al.

JOURNAL OF ELECTROCARDIOLOGY (2019)

Article Cardiac & Cardiovascular Systems

Mobile Photoplethysmographic Technology to Detect Atrial Fibrillation

Yutao Guo et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)

Article Medicine, General & Internal

Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation

Marco V. Perez et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Cardiac & Cardiovascular Systems

EHRA White Paper: knowledge gaps in arrhythmia management-status 2019

Andreas Goette et al.

EUROPACE (2019)

Article Cardiac & Cardiovascular Systems

Atrial Remodeling Following Catheter Ablation for Atrial Fibrillation-Mediated Cardiomyopathy Long-Term Follow-Up of CAMERA-MRI Study

Hariharan Sugumar et al.

JACC-CLINICAL ELECTROPHYSIOLOGY (2019)

Review Cardiac & Cardiovascular Systems

Atrial Myopathy

Mark J. Shen et al.

JACC-BASIC TO TRANSLATIONAL SCIENCE (2019)

Review Cardiac & Cardiovascular Systems

Does atrial fibrillation cause cognitive decline and dementia?

Joanna Dietzel et al.

EUROPACE (2018)

Article Cardiac & Cardiovascular Systems

Use of Atrial Strain to Predict Atrial Fibrillation After Cerebral Ischemia

Faraz Pathan et al.

JACC-CARDIOVASCULAR IMAGING (2018)

Article Cardiac & Cardiovascular Systems

The Optimal Anti-Coagulation for Enhanced-Risk Patients Post-Catheter Ablation for Atrial Fibrillation (OCEAN) trial

Atul Verma et al.

AMERICAN HEART JOURNAL (2018)

Article Cardiac & Cardiovascular Systems

Characterization of Low-Voltage Areas in Patients With Atrial Fibrillation: Insights From High-Density Intracardiac Mapping

Pablo B. Nery et al.

CANADIAN JOURNAL OF CARDIOLOGY (2018)

Article Cardiac & Cardiovascular Systems

Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation

Paulus Kirchhof et al.

EUROPEAN HEART JOURNAL (2018)

Article Medicine, General & Internal

Catheter Ablation for Atrial Fibrillation with Heart Failure

Nassir F. Marrouche et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Cardiac & Cardiovascular Systems

Passive Detection of Atrial Fibrillation Using a Commercially Available Smartwatch

Geoffrey H. Tison et al.

JAMA CARDIOLOGY (2018)

Article Geriatrics & Gerontology

Continued Use of Warfarin in Veterans with Atrial Fibrillation After Dementia Diagnosis

Ariela R. Orkaby et al.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2017)

Article Cardiac & Cardiovascular Systems

Left Atrial Fibrosis and Risk of Cerebrovascular and Cardiovascular Events in Patients With Atrial Fibrillation

Jordan B. King et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)

Article Cardiac & Cardiovascular Systems

Catheter Ablation Versus Medical Rate Control in Atrial Fibrillation and Systolic Dysfunction The CAMERA-MRI Study

Sandeep Prabhu et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)

Article Cardiac & Cardiovascular Systems

Screening for Atrial Fibrillation A Report of the AF-SCREEN International Collaboration

Ben Freedman et al.

CIRCULATION (2017)

Article Cardiac & Cardiovascular Systems

Defining the major health modifiers causing atrial fibrillation: a roadmap to underpin personalized prevention and treatment

Larissa Fabritz et al.

NATURE REVIEWS CARDIOLOGY (2016)

Article Cardiac & Cardiovascular Systems

The Impact of Duration of Atrial Fibrillation Recurrences on Measures of Health-Related Quality of Life and Symptoms

Simon Kochhaeuser et al.

PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2016)

Article Cardiac & Cardiovascular Systems

Geographic and socio-demographic differences in uptake of population-based screening for atrial fibrillation: The STROKESTOP I study

Johan Engdahl et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)

Article Cardiac & Cardiovascular Systems

Left Atrial Geometry Improves Risk Prediction of Thromboembolic Events in Patients With Atrial Fibrillation

Felipe Bisbal et al.

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2016)

Article Cardiac & Cardiovascular Systems

Atrial fibrillation and rapid acute pacing regulate adipocyte/adipositas-related gene expression in the atria

R. K. Chilukoti et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)

Article Cardiac & Cardiovascular Systems

Real life anticoagulation treatment of patients with atrial fibrillation in Germany: extent and causes of anticoagulant under-use

Thomas Wilke et al.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2015)

Review Cardiac & Cardiovascular Systems

The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trials

Stefan D. Anker et al.

EUROPEAN HEART JOURNAL (2014)

Article Medicine, General & Internal

Effect of a patient-directed discharge letter on patient understanding of their hospitalisation

R. Lin et al.

INTERNAL MEDICINE JOURNAL (2014)

Article Medicine, General & Internal

Association of Atrial Tissue Fibrosis Identified by Delayed Enhancement MRI and Atrial Fibrillation Catheter Ablation The DECAAF Study

Nassir F. Marrouche et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)

Article Cardiac & Cardiovascular Systems

Left Atrial Sphericity: A New Method to Assess Atrial Remodeling. Impact on the Outcome of Atrial Fibrillation Ablation

Felipe Bisbal et al.

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2013)

Article Cardiac & Cardiovascular Systems

Left Atrial Strain Is Reduced in Patients with Atrial Fibrillation, Stroke or TIA, and Low Risk CHADS2 Scores

Talhat Azemi et al.

JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2012)

Article Cardiac & Cardiovascular Systems

Development and Validation of the Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) Questionnaire in Patients With Atrial Fibrillation

John Spertus et al.

CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2011)

Article Cardiac & Cardiovascular Systems

Association of Left Atrial Fibrosis Detected by Delayed-Enhancement Magnetic Resonance Imaging and the Risk of Stroke in Patients With Atrial Fibrillation

Marcos Daccarett et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)

Article Cardiac & Cardiovascular Systems

Cognitive Function and Anticoagulation Control in Patients With Atrial Fibrillation

Greg C. Flaker et al.

CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2010)

Article Medicine, General & Internal

Comparison of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation A Randomized Controlled Trial

David J. Wilber et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)

Article Medicine, General & Internal

Effect of Dronedarone on Cardiovascular Events in Atrial Fibrillation

Stefan H. Hohnloser et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Article Medicine, General & Internal

Rhythm control versus rate control for atrial fibrillation and heart failure

Denis Roy et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Article Cardiac & Cardiovascular Systems

Altered expression of ADAMS (A Disintegrin And Metalloproteinase) in fibrillating human atria

M Arndt et al.

CIRCULATION (2002)